Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Sep;41(3):1150–1156. doi: 10.1128/iai.41.3.1150-1156.1983

Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis.

D G Burstyn, L J Baraff, M S Peppler, R D Leake, J St Geme Jr, C R Manclark
PMCID: PMC264620  PMID: 6309662

Abstract

Serum antibody responses to the filamentous hemagglutinin and the lymphocytosis-promoting toxin of Bordetella pertussis after vaccination with diphtheria and tetanus toxoids and pertussis vaccine, adsorbed, were assayed by using the enzyme-linked immunosorbent assay. The effect of early immunization, during the first week of life, on the antibody response also was determined. After vaccination, immunoglobulin G (IgG) and IgM directed against both the filamentous hemagglutinin and the lymphocytosis-promoting toxin were detected. Generally, antibody titers increased with subsequent injections and the age of the children. Maternal antibodies against filamentous hemagglutinin and lymphocytosis-promoting toxin were detected in cord blood. The ability of an infant to produce serum IgG anti-lymphocytosis-promoting toxin after vaccination with pertussis vaccine was inversely related to the cord blood serum IgG anti-lymphocytosis-promoting toxin titer at birth. A good antibody response was observed in infants with low cord blood titers, and a poor antibody response was seen in infants with high cord blood values. The IgM anti-lymphocytosis-promoting toxin response was good in groups with both low and high cord blood titer, with no significant difference observed between the two groups. No IgA anti-lymphocytosis-promoting toxin or IgA anti-filamentous hemagglutinin titers were observed in vaccines. IgA antibodies were observed in convalescent sera from two adults and may be presumptive evidence of infection with B. pertussis.

Full text

PDF
1150

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott J. D., Preston N. W., Mackay R. I. Agglutinin response to pertussis vaccination in the child. Br Med J. 1971 Jan 9;1(5740):86–88. doi: 10.1136/bmj.1.5740.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aftandelians R., Connor J. D. Bactericidal antibody in serum during infection with Bordetalla pertussis. J Infect Dis. 1973 Oct;128(4):555–558. doi: 10.1093/infdis/128.4.555. [DOI] [PubMed] [Google Scholar]
  3. Albrecht P., Ennis F. A., Saltzman E. J., Krugman S. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr. 1977 Nov;91(5):715–718. doi: 10.1016/s0022-3476(77)81021-4. [DOI] [PubMed] [Google Scholar]
  4. BROWN G. C., VOLK V. K., GOTTSHALL R. Y., KENDRICK P. L., ANDERSON H. D. RESPONSES OF INFANTS TO DTP-P VACCINE USED IN NINE INJECTION SCHEDULES. Public Health Rep. 1964 Jul;79:585–602. [PMC free article] [PubMed] [Google Scholar]
  5. Barkin R. M., Pichichero M. E. Diphtheria-pertussis-tetanus vaccine: reactogenicity of commercial products. Pediatrics. 1979 Feb;63(2):256–260. [PubMed] [Google Scholar]
  6. Bradstreet C. M., Tannahill A. J., Edwards J. M., Benson P. F. Detection of Bordetella pertussis antibodies in human sera by complement-fixation and immunofluorescence. J Hyg (Lond) 1972 Mar;70(1):75–83. doi: 10.1017/s0022172400022117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cody C. L., Baraff L. J., Cherry J. D., Marcy S. M., Manclark C. R. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 1981 Nov;68(5):650–660. [PubMed] [Google Scholar]
  8. Dolby J. M., Stephens S. Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection. J Hyg (Lond) 1973 Mar;71(1):193–207. doi: 10.1017/s0022172400046362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol. 1972 Jul;109(1):129–135. [PubMed] [Google Scholar]
  10. GOERKE L. S., ROBERTS P., CHAPMAN J. M. Neonatal response to DTP vaccines. Public Health Rep. 1958 Jun;73(6):511–519. [PMC free article] [PubMed] [Google Scholar]
  11. Geller B. D., Pittman M. immunoglobulin and histamine-sensitivity response of mice to live Bordetella pertussis. Infect Immun. 1973 Jul;8(1):83–90. doi: 10.1128/iai.8.1.83-90.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goodman Y. E., Wort A. J., Jackson F. L. Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin A in nasopharyngeal secretions as an indicator of recent infection. J Clin Microbiol. 1981 Feb;13(2):286–292. doi: 10.1128/jcm.13.2.286-292.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Granström M., Granström G., Lindfors A., Askelöf P. Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen. J Infect Dis. 1982 Dec;146(6):741–745. doi: 10.1093/infdis/146.6.741. [DOI] [PubMed] [Google Scholar]
  14. Granström M., Lindberg A. A., Askelöf P., Hederstedt B. Detection of antibodies in human serum against the fimbrial haemagglutinin of Bordetella pertussis by enzyme-linked immunosorbent assay. J Med Microbiol. 1982 Feb;15(1):85–96. doi: 10.1099/00222615-15-1-85. [DOI] [PubMed] [Google Scholar]
  15. MARTIN DU PAN R. The vaccination of the newborn infant against pertussis. J Pediatr. 1958 Aug;53(2):180–186. doi: 10.1016/s0022-3476(58)80170-5. [DOI] [PubMed] [Google Scholar]
  16. Macaulay M. E. The IgM and IgG response to Bordetella pertussis vaccination and infection. J Med Microbiol. 1981 Feb;14(1):1–7. doi: 10.1099/00222615-14-1-1. [DOI] [PubMed] [Google Scholar]
  17. Macaulay M. E. The serological diagnosis of whooping cough. J Hyg (Lond) 1979 Aug;83(1):95–102. doi: 10.1017/s0022172400025857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Manclark C. R. Pertussis vaccine research. Bull World Health Organ. 1981;59(1):9–15. [PMC free article] [PubMed] [Google Scholar]
  19. Munoz J. J., Arai H., Cole R. L. Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infect Immun. 1981 Apr;32(1):243–250. doi: 10.1128/iai.32.1.243-250.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. OSBORN J. J., DANCIS J., JULIA J. F. Studies of the immunology of the newborn infant. II. Interference with active immunization by passive transplacental circulating antibody. Pediatrics. 1952 Sep;10(3):328–334. [PubMed] [Google Scholar]
  21. Provenzano R. W., Wetterlow L. H., Sullivan C. L. Immunization and antibody response in the newborn infant. I. Pertussis inoculation within twenty-four hours of birth. N Engl J Med. 1965 Oct 28;273(18):959–965. doi: 10.1056/NEJM196510282731804. [DOI] [PubMed] [Google Scholar]
  22. REILLY C. M., STOKES J., Jr, BUYNAK E. B., GOLDNER H., HILLEMAN M. R. Living attenuated measles-virus vaccine in early infancy. Studies of the role of passive antibody in immunization. N Engl J Med. 1961 Jul 27;265:165–169. doi: 10.1056/NEJM196107272650403. [DOI] [PubMed] [Google Scholar]
  23. Ruuskanen O., Viljanen M. K., Salmi T. T., Lehtonen O. P., Kouvalainen K., Peltonen T. DTP and DTP-inactivated polio vaccines: comparison of adverse reactions and IGG, IGM and IGA antibody responses to DTP. Acta Paediatr Scand. 1980 Mar;69(2):177–182. doi: 10.1111/j.1651-2227.1980.tb07056.x. [DOI] [PubMed] [Google Scholar]
  24. Sato Y., Cowell J. L., Sato H., Burstyn D. G., Manclark C. R. Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun. 1983 Jul;41(1):313–320. doi: 10.1128/iai.41.1.313-320.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sato Y., Izumiya K., Sato H., Cowell J. L., Manclark C. R. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun. 1981 Mar;31(3):1223–1231. doi: 10.1128/iai.31.3.1223-1231.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. TURNER T. B., VELASCO-JOVEN E. A., PRUDOVSKY S. Studies on the prophylaxis and treatment of tetanus. II. Studies pertaining to treatment. Bull Johns Hopkins Hosp. 1958 Feb;102(2):71–84. [PubMed] [Google Scholar]
  27. Thomas G. Respiratory and humoral immune response to aerosol and intramuscular pertussis vaccine. J Hyg (Lond) 1975 Apr;74(2):233–237. doi: 10.1017/s0022172400024293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Viljanen M. K., Ruuskanen O., Granberg C., Salmi T. T. Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis. 1982;14(2):117–122. doi: 10.3109/inf.1982.14.issue-2.08. [DOI] [PubMed] [Google Scholar]
  29. WINTER J. L. Development of antibodies in children convalescent from whooping cough. Proc Soc Exp Biol Med. 1953 Aug-Sep;83(4):866–870. doi: 10.3181/00379727-83-20517. [DOI] [PubMed] [Google Scholar]
  30. Wilkins J., Williams F. F., Wehrle P. F., Portnoy B. Agglutinin response to pertussis vaccine. I. Effect of dosage and interval. J Pediatr. 1971 Aug;79(2):197–202. doi: 10.1016/s0022-3476(71)80101-4. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES